牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) has reported a transaction involving Chief Financial Officer & Executive Vice President Denton David M. The transaction, dated 02/27/2024, did not specify the number of shares traded or the transaction price. As a result, the total value of the shares and the number of shares held after the action remain undisclosed. This announcement is part of the standard disclosure requirements for executives and may be of interest to investors monitoring insider activities within Pfizer.
Pfizer Inc. (PFE) has reported a transaction involving Chief Financial Officer & Executive Vice President Denton David M. The transaction, dated 02/27/2024, did not specify the number of shares traded or the transaction price. As a result, the total value of the shares and the number of shares held after the action remain undisclosed. This announcement is part of the standard disclosure requirements for executives and may be of interest to investors monitoring insider activities within Pfizer.
輝瑞公司（PFE）報告了一筆涉及首席財務官兼執行副總裁丹頓·戴維·M的交易。該交易於2024年2月27日進行，沒有具體說明交易的股票數量或交易價格。因此，股票的總價值和行動後持有的股票數量仍未披露。該公告是高管標準披露要求的一部分，監督輝瑞內部活動的投資者可能會對此感興趣。
輝瑞公司（PFE）報告了一筆涉及首席財務官兼執行副總裁丹頓·戴維·M的交易。該交易於2024年2月27日進行，沒有具體說明交易的股票數量或交易價格。因此，股票的總價值和行動後持有的股票數量仍未披露。該公告是高管標準披露要求的一部分，監督輝瑞內部活動的投資者可能會對此感興趣。
有用
沒用